- Home
- VALN vs RFI Comparison
VALN vs RFI Comparison
Compare VALN & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- RFI
- Stock Information
- Founded
- VALN 2012
- RFI 1992
- Country
- VALN France
- RFI United States
- Employees
- VALN N/A
- RFI N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- RFI Investment Managers
- Sector
- VALN Health Care
- RFI Finance
- Exchange
- VALN Nasdaq
- RFI Nasdaq
- Market Cap
- VALN 345.2M
- RFI 311.2M
- IPO Year
- VALN 2021
- RFI N/A
- Fundamental
- Price
- VALN $4.36
- RFI $11.95
- Analyst Decision
- VALN Strong Buy
- RFI
- Analyst Count
- VALN 2
- RFI 0
- Target Price
- VALN $18.50
- RFI N/A
- AVG Volume (30 Days)
- VALN 68.4K
- RFI 69.8K
- Earning Date
- VALN 11-07-2024
- RFI 01-01-0001
- Dividend Yield
- VALN N/A
- RFI 8.25%
- EPS Growth
- VALN N/A
- RFI N/A
- EPS
- VALN N/A
- RFI N/A
- Revenue
- VALN $176,817,979.00
- RFI N/A
- Revenue This Year
- VALN $24.66
- RFI N/A
- Revenue Next Year
- VALN $9.67
- RFI N/A
- P/E Ratio
- VALN N/A
- RFI N/A
- Revenue Growth
- VALN N/A
- RFI N/A
- 52 Week Low
- VALN $3.62
- RFI $9.62
- 52 Week High
- VALN $9.50
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- VALN 48.76
- RFI 53.04
- Support Level
- VALN $4.22
- RFI $11.42
- Resistance Level
- VALN $4.51
- RFI $11.85
- Average True Range (ATR)
- VALN 0.21
- RFI 0.17
- MACD
- VALN 0.00
- RFI 0.07
- Stochastic Oscillator
- VALN 41.90
- RFI 92.98
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.